Health and Healthcare

What to Expect When Mylan Reports Earnings

Thinkstock

Mylan N.V. (NASDAQ: MYL) is set to release its second-quarter financial results after the markets close on Tuesday. The consensus estimates from Thomson Reuters are calling for $1.14 in earnings per share (EPS) on $2.57 billion in revenue. Mylan posted EPS of $0.91 and $2.37 billion in revenue in the same period of last year.

This is an analyst favorite and it sports a very appealing valuation. Mylan develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals worldwide.

Like other major pharmaceutical companies, Mylan provides generic or branded generic pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, cream or ointment forms, as well as active pharmaceutical ingredients (APIs). It is also involved in the development of APIs with non-infringing processes for internal use and to partner with manufacturers, and the manufacture and sale of injectable products in antineoplastics, anti-infectives, anesthesia/pain management and cardiovascular therapeutic areas.

Mylan had attempted a takeover of drugmaker Perrigo last year, which was fought off, and the company has since announced the purchase of Meda and recent acquisition of Renaissance. Some analysts love the company’s very attractive valuation, and trading at roughly 10 times estimated 2016 earnings per share, it clearly is cheap.

Ahead during the second quarter, a few analysts weighed in on Mylan:

  • Morgan Stanley reiterated a Hold rating.
  • JPMorgan reiterated an Overweight rating.
  • Goldman Sachs has a Buy rating with a $60 price target.

Excluding Tuesday’s move, Mylan has underperformed the broad markets, with the stock down 10%. Over the past 52 weeks, the stock is down 14%, but in just the last quarter the stock is up 19%.

Shares of Mylan were trading up 3% at $50.10 on Tuesday, with a consensus analyst price target of $58.06 and a 52-week trading range of $37.59 to $57.77.

The Average American Has No Idea How Much Money You Can Make Today (Sponsor)

The last few years made people forget how much banks and CD’s can pay. Meanwhile, interest rates have spiked and many can afford to pay you much more, but most are keeping yields low and hoping you won’t notice.

But there is good news. To win qualified customers, some accounts are paying almost 10x the national average! That’s an incredible way to keep your money safe and earn more at the same time. Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 3.80% with a Checking & Savings Account today Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.

Click here to see how much more you could be earning on your savings today. It takes just a few minutes to open an account to make your money work for you.

 

Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 4.00% with a Checking & Savings Account from Sofi. Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.

1 https://www.fdic.gov/national-rates-and-rate-caps

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.

AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.